Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02723006 |
Title | Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Millennium Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Arizona Cancer Center | Tucson | Arizona | United States | Details | ||
University of California Los Angeles - Jonsson Comprehensive Cancer Center | Los Angeles | California | United States | Details | ||
University of California San Francisco Medical Center | San Francisco | California | United States | Details | ||
University of Colorado Cancer Center | Aurora | Colorado | United States | Details | ||
Emory University Hospital | Atlanta | Georgia | United States | Details | ||
Dana-Farber Cancer Institute | Boston | Massachusetts | United States | Details | ||
Massachusetts General Hospital Cancer Center | Boston | Massachusetts | United States | Details | ||
Virginia Piper Cancer Institute | Minneapolis | Minnesota | United States | Details | ||
Washington University School of Medicine | Saint Louis | Missouri | United States | Details | ||
New York University Langone Medical Center | New York | New York | United States | Details | ||
Saint Luke's Cancer Center - Bethlehem | Easton | Pennsylvania | United States | Details | ||
Fox Chase Cancer Center | Philadelphia | Pennsylvania | United States | Details | ||
Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | United States | Details | ||
Inova Fairfax Hospital | Fairfax | Virginia | United States | Details |